GSK’s Sluggish Shares Seen at Risk of New Activist Campaign
GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine ...
GSK seen as potential target for activist investors
Drugmaker GSK has been tapped as a potential target for activist investors, according to Bloomberg, which noted that shares had fallen roughly 19% since spinning off its consumer health business in ...
Hosted on MSN14h
Drug industry sees partnership with Trump, RFK Jr.
The pharmaceutical industry is framing itself as a key partner for President Trump and HHS Secretary Robert F. Kennedy Jr. in ...
The Sunday Business Post23h
Pharma giant GSK’s underperformance leaves it at risk of renewed activist campaign
The pharma giant has operated in Ireland for decades and continues to have operations in key locations such as Cork and ...